Northern Trust’s VectivBio Holding VECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-3,361
Closed -$17K – 4832
2021
Q4
$17K Buy
+3,361
New +$16.6K ﹤0.01% 4721
2021
Q3
– Sell
-7,159
Closed -$83K – 4772
2021
Q2
$83K Buy
+7,159
New +$109K ﹤0.01% 4406

Other funds holding VECT

Northern Trust's VECT Position: Q1 2022 in Review

Northern Trust sold out of VectivBio Holding (VECT) in Q1 2022, closing a stake of 3,361 shares — an estimated $17K sold.

Northern Trust first reported a position in VECT in Q2 2021 and held it in 2 quarters. The position peaked at $83K in Q2 2021. 17 funds tracked by Wall St. Rank hold VECT as of Q1 2022.

  • Northern Trust reported no remaining VectivBio Holding position as of Q1 2022 after selling out during the quarter.
  • Northern Trust sold 3,361 VectivBio Holding shares in Q1 2022, an estimated $17K.
  • Northern Trust first reported a position in VectivBio Holding in Q2 2021 and held it in 2 quarters.
  • Northern Trust's VectivBio Holding position peaked at $83K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held VectivBio Holding as of Q1 2022.

Based on Northern Trust's 13F filing for Q1 2022, filed 13 May 2022.